Literature DB >> 10431243

Engineering a mouse balancer chromosome.

B Zheng1, M Sage, W W Cai, D M Thompson, B C Tavsanli, Y C Cheah, A Bradley.   

Abstract

Balancer chromosomes are genetic reagents that are used in Drosophila melanogaster for stock maintenance and mutagenesis screens. Despite their utility, balancer chromosomes are rarely used in mice because they are difficult to generate using conventional methods. Here we describe the engineering of a mouse balancer chromosome with the Cre-loxP recombination system. The chromosome features a 24-centiMorgan (cM) inversion between Trp53 (also known as p53) and Wnt3 on mouse chromosome 11 that is recessive lethal and dominantly marked with a K14-Agouti transgene. When allelic to a wild-type chromosome, the inversion suppresses crossing over in the inversion interval, accompanied by elevated recombination in the flanking regions. The inversion functions as a balancer chromosome because it can be used to maintain a lethal mutation in the inversion interval as a self-sustaining trans-heterozygous stock. This strategy can be used to generate similar genetic reagents throughout the mouse genome. Engineering of visibly marked inversions and deficiencies is an important step toward functional analyses of the mouse genome and will facilitate large-scale mutagenesis programs.

Entities:  

Mesh:

Year:  1999        PMID: 10431243     DOI: 10.1038/11949

Source DB:  PubMed          Journal:  Nat Genet        ISSN: 1061-4036            Impact factor:   38.330


  44 in total

1.  Engineering mouse chromosomes with Cre-loxP: range, efficiency, and somatic applications.

Authors:  B Zheng; M Sage; E A Sheppeard; V Jurecic; A Bradley
Journal:  Mol Cell Biol       Date:  2000-01       Impact factor: 4.272

2.  Targeted Chromosomal Translocations and Essential Gene Knockout Using CRISPR/Cas9 Technology in Caenorhabditis elegans.

Authors:  Xiangyang Chen; Mu Li; Xuezhu Feng; Shouhong Guang
Journal:  Genetics       Date:  2015-10-19       Impact factor: 4.562

Review 3.  N-ethyl-N-nitrosourea mutagenesis: boarding the mouse mutant express.

Authors:  Sabine P Cordes
Journal:  Microbiol Mol Biol Rev       Date:  2005-09       Impact factor: 11.056

4.  Induced mitotic recombination of p53 in vivo.

Authors:  Wei Wang; Madhuri Warren; Allan Bradley
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-05       Impact factor: 11.205

5.  Rpl27a mutation in the sooty foot ataxia mouse phenocopies high p53 mouse models.

Authors:  Tamara Terzian; Melissa Dumble; Farinaz Arbab; Christina Thaller; Lawrence A Donehower; Guillermina Lozano; Monica J Justice; Dennis R Roop; Neil F Box
Journal:  J Pathol       Date:  2011-06-14       Impact factor: 7.996

6.  COP9 signalosome subunit 3 is essential for maintenance of cell proliferation in the mouse embryonic epiblast.

Authors:  Jiong Yan; Katherina Walz; Hisashi Nakamura; Sandra Carattini-Rivera; Qi Zhao; Hannes Vogel; Ning Wei; Monica J Justice; Allan Bradley; James R Lupski
Journal:  Mol Cell Biol       Date:  2003-10       Impact factor: 4.272

7.  Genetic control of X chromosome inactivation in mice: definition of the Xce candidate interval.

Authors:  Lisa Helbling Chadwick; Lisa M Pertz; Karl W Broman; Marisa S Bartolomei; Huntington F Willard
Journal:  Genetics       Date:  2006-04-02       Impact factor: 4.562

8.  An efficient method to generate chromosomal rearrangements by targeted DNA double-strand breaks in Drosophila melanogaster.

Authors:  Dieter Egli; Ernst Hafen; Walter Schaffner
Journal:  Genome Res       Date:  2004-06-14       Impact factor: 9.043

9.  A mouse chromosome 4 balancer ENU-mutagenesis screen isolates eleven lethal lines.

Authors:  Melissa K Boles; Bonney M Wilkinson; Andrea Maxwell; Lihua Lai; Alea A Mills; Ichiko Nishijima; Andrew P Salinger; Ivan Moskowitz; Karen K Hirschi; Bin Liu; Allan Bradley; Monica J Justice
Journal:  BMC Genet       Date:  2009-03-06       Impact factor: 2.797

10.  Discovery of candidate disease genes in ENU-induced mouse mutants by large-scale sequencing, including a splice-site mutation in nucleoredoxin.

Authors:  Melissa K Boles; Bonney M Wilkinson; Laurens G Wilming; Bin Liu; Frank J Probst; Jennifer Harrow; Darren Grafham; Kathryn E Hentges; Lanette P Woodward; Andrea Maxwell; Karen Mitchell; Michael D Risley; Randy Johnson; Karen Hirschi; James R Lupski; Yosuke Funato; Hiroaki Miki; Pablo Marin-Garcia; Lucy Matthews; Alison J Coffey; Anne Parker; Tim J Hubbard; Jane Rogers; Allan Bradley; David J Adams; Monica J Justice
Journal:  PLoS Genet       Date:  2009-12-11       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.